{"id":141647,"date":"2023-02-14T10:30:51","date_gmt":"2023-02-14T15:30:51","guid":{"rendered":"https:\/\/44.250.171.167\/?p=141647"},"modified":"2023-02-14T10:30:52","modified_gmt":"2023-02-14T15:30:52","slug":"biocon-ltd-nse-biocon-ltd-q3-fy23-results-out-total-income-rise-35-yoy","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/biocon-ltd-nse-biocon-ltd-q3-fy23-results-out-total-income-rise-35-yoy\/","title":{"rendered":"Biocon ltd.(NSE: BIOCON) Ltd. : Q3 FY23 Results Out; Total Income rise 35% YoY"},"content":{"rendered":"\n<p><a href=\"https:\/\/44.250.171.167\/symbol\/biocon\/\">Biocon Limited (NSE:BIOCON)<\/a> is an Indian multinational biopharmaceutical company based in Bangalore, India. The company was founded in 1978 by Kiran Mazumdar-Shaw and is now one of the largest biopharmaceutical companies in India. Biocon is primarily engaged in the production of biosimilars, generic biologics, and research-based pharmaceuticals. It also has a presence in the areas of medical devices and nutraceuticals. The company has a strong focus on research and development and has collaborations with several global pharmaceutical companies to develop and market new drugs. Biocon has operations in India, the US, Europe, and other countries in the Asia-Pacific region.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"804\" height=\"1024\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/5ae0e933-d8c2-4fc6-912a-65a97b6504cf-804x1024.png\" alt=\"\" class=\"wp-image-141648\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/5ae0e933-d8c2-4fc6-912a-65a97b6504cf-804x1024.png 804w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/5ae0e933-d8c2-4fc6-912a-65a97b6504cf-235x300.png 235w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/5ae0e933-d8c2-4fc6-912a-65a97b6504cf-768x978.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/5ae0e933-d8c2-4fc6-912a-65a97b6504cf-1206x1536.png 1206w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/5ae0e933-d8c2-4fc6-912a-65a97b6504cf-1608x2048.png 1608w\" sizes=\"auto, (max-width: 804px) 100vw, 804px\" \/><\/figure>\n\n\n\n<p>Biocon Ltd reported a 36% increase in consolidated revenue to Rs 3,020 crore in Q3FY23. The robust performance was driven by a 54% increase in revenue from its Biosimilars business, which contributed the most to the company&#8217;s revenue. The Research Services and Generics businesses also reported revenue growth of 23% and 18%, respectively. The company&#8217;s net profit (excluding exceptional items) stood at Rs 140 crore. Biocon&#8217;s EBITDA grew by 35% to Rs 723 crore, with a healthy EBITDA margin of 24%. The company&#8217;s core EBITDA grew by 49% to Rs 1,069 crore. Biocon Biologics is expected to exit the year at a USD 1 billion trajectory, excluding vaccines, and the company is on track to end FY23 on a strong note with healthy growth across all its businesses.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Biocon Limited (NSE:BIOCON) is an Indian multinational biopharmaceutical company based in Bangalore, India. The company was founded in 1978 by Kiran Mazumdar-Shaw and is now one of the largest biopharmaceutical companies in India. Biocon is primarily engaged in the production of biosimilars, generic biologics, and research-based pharmaceuticals. It also has a presence in the areas [&hellip;]<\/p>\n","protected":false},"author":1932,"featured_media":141648,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392,5747],"tags":[1115],"class_list":["post-141647","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","category-healthcare-stocks","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/5ae0e933-d8c2-4fc6-912a-65a97b6504cf.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":148689,"url":"https:\/\/alphastreet.com\/india\/biocon-ltd-driving-growth-in-pharmaceutical-industry\/","url_meta":{"origin":141647,"position":0},"title":"Biocon Ltd.: Driving Growth in Pharmaceutical Industry.","author":"Divyansh_Kasana","date":"June 16, 2023","format":false,"excerpt":"Stock Data: TickerNSE: BIOCONExchangeNSEIndustryPHARMACEUTICALS Price Performance: Last 5 Days+1.43%YTD-7.18%Last 12 Months-22.16%As on 16-06-2023 Company Description: Biocon is India's premier biotechnology company. It has evolved into a fully integrated biopharmaceutical player with API manufacturing facilities, strong capabilities in biologics, innovative drug development, and a branded generics business in India. With over\u2026","rel":"","context":"In &quot;Research Summary&quot;","block_context":{"text":"Research Summary","link":"https:\/\/alphastreet.com\/india\/category\/research-summary\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/06\/f6ceac66-f2a3-45a2-ae80-d4455cad9356-7.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/06\/f6ceac66-f2a3-45a2-ae80-d4455cad9356-7.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/06\/f6ceac66-f2a3-45a2-ae80-d4455cad9356-7.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/06\/f6ceac66-f2a3-45a2-ae80-d4455cad9356-7.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/06\/f6ceac66-f2a3-45a2-ae80-d4455cad9356-7.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/06\/f6ceac66-f2a3-45a2-ae80-d4455cad9356-7.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":147229,"url":"https:\/\/alphastreet.com\/india\/alphagraph-biocon-limited-nse-biocon-q4fy23-results-out-total-income-rises-58-yoy\/","url_meta":{"origin":141647,"position":1},"title":"Alphagraph | Biocon Limited (NSE: BIOCON): Q4FY23 Results Out; Total Income rises 58% YoY.","author":"Divyansh_Kasana","date":"May 24, 2023","format":false,"excerpt":"Biocon is a prominent player in the biotechnology industry, specializing in the manufacturing of biotechnology products and offering research services. With a strong focus on innovation and scientific expertise, Biocon has made significant contributions to the field of biotechnology. The company's diverse portfolio encompasses a range of biopharmaceuticals, including biosimilars,\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/213490c7-5a56-4586-825e-f4dfdab0cb23-1.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/213490c7-5a56-4586-825e-f4dfdab0cb23-1.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/213490c7-5a56-4586-825e-f4dfdab0cb23-1.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/213490c7-5a56-4586-825e-f4dfdab0cb23-1.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/213490c7-5a56-4586-825e-f4dfdab0cb23-1.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/213490c7-5a56-4586-825e-f4dfdab0cb23-1.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":157327,"url":"https:\/\/alphastreet.com\/india\/biocon-ltd-q2fy24-111-rise-in-profits\/","url_meta":{"origin":141647,"position":2},"title":"Biocon Ltd Q2FY24; 111% rise in Profits","author":"Divyansh_Kasana","date":"December 14, 2023","format":false,"excerpt":"Biocon is engaged in the business of manufacture of biotechnology products and research services. Financial Results: Biocon Ltd reported Revenues for Q2FY24 of \u20b93,462.00 Crores up from \u20b92,320.00 Crore year on year, a rise of 49.22%. Total Expenses for Q2FY24 of \u20b93,382.00 Crores up from \u20b92,138.00 Crores year on year,\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-106.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-106.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-106.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-106.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-106.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-106.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":161804,"url":"https:\/\/alphastreet.com\/india\/biocon-ltd-q4fy24-46-fall-in-profits\/","url_meta":{"origin":141647,"position":3},"title":"Biocon Ltd Q4FY24; 46% fall in Profits","author":"Divyansh_Kasana","date":"June 3, 2024","format":false,"excerpt":"Biocon is engaged in the business of manufacture of biotechnology products and research services.(Source : 202003-01 Annual Report Page No:195) Financial Results: Biocon Ltd reported Revenues for Q4FY24 of \u20b93,917.00 Crores up from \u20b93,774.00 Crore year on year, a rise of 3.79%. Total Expenses for Q4FY24 of \u20b93,638.00 Crores up\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-23.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-23.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-23.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-23.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-23.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-23.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":152755,"url":"https:\/\/alphastreet.com\/india\/biocon-ltd-q1fy24-11-fall-in-profits\/","url_meta":{"origin":141647,"position":4},"title":"Biocon Ltd Q1FY24; 11% fall in Profits","author":"Divyansh_Kasana","date":"August 11, 2023","format":false,"excerpt":"Biocon is engaged in the business of manufacture of biotechnology products and research services.(Source : 202003-01 Annual Report Page No:195) Financial Results: Biocon Ltd reported Revenues for Q1FY24 of \u20b93,423.00 Crores up from \u20b92,140.00 Crore year on year, a rise of 59.95%. Total Expenses for Q1FY24 of \u20b93,332.00 Crores up\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-694.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-694.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-694.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-694.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-694.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-694.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":159664,"url":"https:\/\/alphastreet.com\/india\/basf-india-ltd-q3fy24-1173-rise-in-profits\/","url_meta":{"origin":141647,"position":5},"title":"Biocon Ltd Q3FY24; 34% rise in Revenue","author":"Divyansh_Kasana","date":"March 8, 2024","format":false,"excerpt":"Biocon is engaged in the business of manufacture of biotechnology products and research services. Financial Results: Biocon Ltd reported Revenues for Q3FY24 of \u20b93,954.00 Crores up from \u20b92,941.00 Crore year on year, a rise of 34.44%. Total Expenses for Q3FY24 of \u20b93,732.00 Crores up from \u20b92,773.00 Crores year on year,\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-96.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-96.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-96.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-96.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-96.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-96.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/141647","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=141647"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/141647\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/141648"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=141647"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=141647"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=141647"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}